Thus, although CgA is a widely used serological and histopathological marker for neuroendocrine tumor diagnosis and follow‐up, development of appropriate models is necessary to address the functional role of CgA and its fragments in patients with such tumors. The gene discussed is CGA; the disease is neuroendocrine neoplasm.